Summary
39 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- It passes 8 of the 9 points of the Piotroski financial health test.
What to watch
- Earnings per share fell by 65% a year over the last 3 years.
- Out of every 100 THB of revenue, only 1.9 THB is left as net profit.
- Operating profit covers the interest on its debt only 1.9 times.
- It earns only 0.9 THB a year on every 100 THB of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapPrice against the Bulios Fair Price
P/E against the industry (Medical - Care Facilities)
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 35.8 THB for 1 THB of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (THB)
Diluted EPS (THB)
- Analyst estimate
Revenue grew by 4.5% a year over 5 years. Over the last 3 years it fell by 7.6% a year. Earnings per share fell by 65% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 THB of revenue goes
- Cost of sales 78 THB
- Sales and administration 19 THB
- Taxes and other 1.6 THB
- Net profit 1.9 THB
Net profit, industry median (Medical - Care Facilities) 6.0 THB
Out of every 100 THB of revenue, 1.9 THB is left as net profit.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 4.3 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail